Dasatinib-based induction and blinatumomab + TKI consolidation/maintenance for BCR::ABL1+ ALL: BLISSPhALL Study Results

Blood Neoplasia · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles